Cancer Detection and Diagnosis Research in Vermont
Cancer Detection and Diagnosis Research (93.394) awarded $1.9 million to recipients in Vermont in 2 grants from fiscal 2021 to 2025, less than 0.1% of the program's national total. Veterans Education and Research Association of Northern New England, Inc. received the most, $1.5 million.
- Awarded in Vermont$1.9 million
- Awards2
- Share of the programless than 0.1%
- Rank among states43rd of 45
- National total$2.7 billion
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | No awards | |
| FY 2022 | 1 | $182,325 |
| FY 2023 | 2 | $798,306 |
| FY 2024 | 1 | $565,926 |
| FY 2025 | 1 | $332,897 |
Recipients in Vermont
| Recipient | Type | Awards | Amount |
|---|---|---|---|
| Veterans Education and Research Association of Northern New England, Inc. | Nonprofits | 1 | $1.5 million |
| University of Vermont & State Agricultural College | Colleges and universities | 1 | $396,739 |
Open opportunities under this program
- Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- Competing Revisions to Existing NIH Single Project Research Grants and Cooperative Agreements (Clinical Trial Optional)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required)
- Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional)
- National Cancer Institute's Investigator-Initiated Early Phase Clinical Trials for Cancer Treatment and Diagnosis (R01 Clinical Trial Required)
- Glioblastoma Therapeutics Network (GTN) (U19 Clinical Trial Required)
- Limited Competition: Biospecimen Banks to support NCI National Clinical Trials Network Biospecimen Banks (NCTN Biobanks) and the NCI Early-Phase and Experimental Clinical Trials Biospecimen Bank (EET Biobank) (U24 Clinical Trial Not Allowed)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NIH Small Business Technology Transfer Grant (Parent STTR [R41/R42] Clinical Trial Optional)
See all 50 on the program page
Questions people ask
How much Cancer Detection and Diagnosis Research money goes to Vermont?
$1.9 million from fiscal 2021 to 2025, across 2 awards. Vermont ranks 43rd of 45 states and territories for this program.
Who receives Cancer Detection and Diagnosis Research money in Vermont?
The largest recipient is Veterans Education and Research Association of Northern New England, Inc., with $1.5 million in 1 award. Next is University of Vermont & State Agricultural College.
Can organizations in Vermont apply now?
Yes, 50 opportunities under this program are open or forecast on Grants.gov. Federal grants are national, so eligibility depends on the notice, not the state.
Cancer Detection and Diagnosis Research in other states
Other large programs in Vermont
- Grants to States for Medicaid
- Highway Planning and Construction
- Disaster Grants - Public Assistance (Presidentially Declared Disasters)
- Education Stabilization Fund
- Temporary Assistance for Needy Families
- Broadband Equity, Access, and Deployment Program
- National School Lunch Program
- Drinking Water State Revolving Fund
- Title I Grants to Local Educational Agencies
- Special Education Grants to States